SAFETY OF LOW-DOSE PROLONGED INFUSION OF TISSUE PLASMINOGEN ACTIVATOR THERAPY IN PATIENTS WITH THROMBOEMBOLIC EVENTS IN THE INTENSIVE CARE UNIT

Kalkan, Mehmet; Yildiz, MUSTAFA; Yilmaz Ak, Hülya; Agus, Hicaz; Özsahin, YASEMİN; Aykan, Ahmet; Oksen, Doğaç

doi:10.18087/cardio.2020.7.n1091

SAFETY OF LOW-DOSE PROLONGED INFUSION OF TISSUE PLASMINOGEN ACTIVATOR THERAPY IN PATIENTS WITH THROMBOEMBOLIC EVENTS IN THE INTENSIVE CARE UNIT

Kalkan M. E., Yildiz M., Yilmaz Ak H., Agus H. Z., Özsahin Y., Aykan A. Ç., ...Daha Fazla

KARDIOLOGIYA, cilt.60, sa.7, ss.86-90, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 60 Sayı: 7
Basım Tarihi: 2020
Doi Numarası: 10.18087/cardio.2020.7.n1091
Dergi Adı: KARDIOLOGIYA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Sayfa Sayıları: ss.86-90
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective Thromboembolic events such as acute coronary syndrome related prosthetic heart valve thrombosis, pulmonary artery embolism and renal artery embolism are a rare condition but a major cause of morbidity and mortality. In this study we discussed low-dose thrombolytic therapy, in patients with thromboembolic events in the intensive care unit.